Beam Therapeutics Stock Forecast

Stock Price Forecast

The 10 analysts with 12-month price forecasts for Beam Therapeutics stock have an average target of 50.5, with a low estimate of 26 and a high estimate of 80. The average target predicts an increase of 158.58% from the current stock price of 19.53.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$26	$50.5	$48	$80
Change	+33.13%	+158.58%	+145.78%	+309.63%

Analyst Ratings

The average analyst rating for Beam Therapeutics stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	2	2	2	2	3	5
Buy	4	4	4	4	4	4
Hold	5	5	4	4	4	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	11	10	10	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Alec Stranahan B of A Securities	B of A Securities	Hold → Strong Buy Upgrades $42	Hold → Strong Buy	Upgrades	$42	+115.05%	Mar 28, 2025
Rick Bienkowski Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Mar 12, 2025
Greg Harrison Scotiabank	Scotiabank	Hold → Buy Upgrades $40	Hold → Buy	Upgrades	$40	+104.81%	Mar 10, 2025
Soumit Roy Jones Trading	Jones Trading	Hold → Strong Buy Upgrades $34	Hold → Strong Buy	Upgrades	$34	+74.09%	Mar 10, 2025
Patrick Trucchio HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $80	Strong Buy	Reiterates	$80	+309.63%	Mar 10, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

60.96M

from 63.52M

-4.02%

from 63.52M

Revenue Next Year

64.82M

from 60.96M

6.32%

from 60.96M

EPS This Year

-4.90

from -4.58

EPS Next Year

-4.93

from -4.90

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	24.00K	51.84M	60.92M	377.71M	63.52M	60.96M	64.82M	75.74M
Revenue Growth	33.33%	215,916.67%	17.51%	520.01%	-83.18%	-4.02%	6.32%	16.85%
EPS	-4.19	-5.77	-4.13	-1.72	-4.58	-4.90	-4.93	-4.94
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	19	19	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	115.5M	168.0M	126.0M
Avg	61.0M	64.8M	75.7M
Low	n/a	n/a	29.4M

Revenue Growth

Revenue Growth	2025	2026	2027
High	81.8%	175.6%	94.4%
Avg	-4.0%	6.3%	16.8%
Low	-	-	-54.6%

EPS Forecast

EPS	2025	2026	2027
High	-3.43	-2.87	-3.16
Avg	-4.90	-4.93	-4.94
Low	-5.87	-6.10	-6.25

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.